您的位置: 首页 > 农业专利 > 详情页

FFA1 (GPR40) as a therapeutic target for neural angiogenesis diseases or disorders
专利权人:
Childrens Medical Center Corporation;Children's Medical Center Corporation
发明人:
Smith, Lois,Joyal, Jean-Sebastien
申请号:
AU2017221441
公开号:
AU2017221441A1
申请日:
2017.02.17
申请国别(地区):
AU
年份:
2018
代理人:
摘要:
The instant invention provides methods and compositions related to discovery of Free Fatty Acid Receptor 1 (FFA1) as a therapeutic target for treatment or prevention of diseases or disorders of neurons that are characterized by angiogenesis, or of vascular diseases of the eye, retinal degeneration and/or tumors more generally. Therapeutic and/or prophylactic uses and compositions of known FFA1 inhibitors, including small molecules and nucleic acid agents, are described. Methods for identification of novel FFA1 inhibitors are also provided.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充